Sean Mackay
Director/Board Member bei Abbratech, Inc.
Profil
Sean Mackay is the founder of IsoPlexis Corp., a company founded in 2013, where he held the title of President, Chief Executive Officer & Director.
He is currently working as a Director at Abbratech, Inc. and as an Operating Partner and Portfolio Advisor at Casdin Capital.
In the past, he worked as the Chief Product Officer at Bruker Cellular Analysis, Inc. Mr. Mackay has a graduate degree from the University of Pennsylvania and an MBA from Yale School of Management.
Aktive Positionen von Sean Mackay
| Unternehmen | Position | Beginn |
|---|---|---|
Abbratech, Inc.
 Abbratech, Inc. BiotechnologyHealth Technology Abbratech, Inc. is a biotechnology company that focuses on precision antibodies. Abbratech is based in Branford, CT. The company offers services such as antigen and project design, recombinant antibody development, antibody optimization, and antibody production. Abbratech uses the best available in vivo and in vitro methods for antibody discovery and applies knowledge gained from the past 15 years of human genome sequencing and antibody engineering to produce high affinity and highly specific recombinant antibodies. The company was founded in 2020 by Michael P. Weiner, who has been the CEO since then. | Director/Board Member | - |
Casdin Capital /Private Equity/
 Casdin Capital /Private Equity/ Investment ManagersFinance Casdin Capital /Private Equity/ (Casdin Capital) is a private equity/venture capital subsidiary of Casdin Capital LLC founded in 2012 by Eli Casdin. The firm is headquartered in New York. | Consultant / Advisor | 01.08.2023 |
Ehemalige bekannte Positionen von Sean Mackay
| Unternehmen | Position | Ende |
|---|---|---|
| BRUKER CELLULAR ANALYSIS, INC. | Corporate Officer/Principal | 02.10.2023 |
| ISOPLEXIS CORPORATION | Founder | 21.03.2023 |
Ausbildung von Sean Mackay
| University of Pennsylvania | Graduate Degree |
| Yale School of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
IsoPlexis Corp.
 IsoPlexis Corp. Packaged SoftwareTechnology Services IsoPlexis Corp. engages in the development of curative medicines and personalized therapeutics. Its single cell proteomics platform, which includes instruments, chip consumables and software, provides an end-to-end solution to reveal a more complete view of protein function at an individual cellular level. The company was founded by Sean Mackay, Rong Fan, and Kara K. Brower in March 2013 and is headquartered in Branford, CT. | Technology Services |
Casdin Capital /Private Equity/
Casdin Capital /Private Equity/ Investment ManagersFinance Casdin Capital /Private Equity/ (Casdin Capital) is a private equity/venture capital subsidiary of Casdin Capital LLC founded in 2012 by Eli Casdin. The firm is headquartered in New York. | Finance |
Abbratech, Inc.
Abbratech, Inc. BiotechnologyHealth Technology Abbratech, Inc. is a biotechnology company that focuses on precision antibodies. Abbratech is based in Branford, CT. The company offers services such as antigen and project design, recombinant antibody development, antibody optimization, and antibody production. Abbratech uses the best available in vivo and in vitro methods for antibody discovery and applies knowledge gained from the past 15 years of human genome sequencing and antibody engineering to produce high affinity and highly specific recombinant antibodies. The company was founded in 2020 by Michael P. Weiner, who has been the CEO since then. | Health Technology |
PhenomeX, Inc.
 PhenomeX, Inc. Packaged SoftwareTechnology Services Bruker Cellular Analysis, Inc. is a biology company that engages in the study of cells. Its tools and services allow the prevention and treatment of disease. The company was founded in 2011 and is headquartered in Emeryville, CA. | Technology Services |
